Today, Kwincy Lassiter is a 25-year-old student enjoying a second chance at life. However, the first 16 years of his sickle cell journey looked much different.

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...

A liver tissueoid-on-a-chip with functional blood vessels, diverse liver cells, and immune activity replicates transplant ...

The NMDP Registry, the most diverse in the world, reports that only 13% of its members identify as Hispanic. For multiracial ...

A new electronic implant system can help lab-grown pancreatic cells mature and function properly, potentially providing a ...

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around allogeneic stem cell transplant. CURE sat down with Dr. Gwen Nichols, chief ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates key structural, functional, and immunological features of ...

MHH doctoral student receives research grant to develop more sustainable methods for cultivating stem cells.

Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By ...

Kennedy Klehr’s routine pregnancy ultrasound revealed her daughter Huxley had a rare genetic condition, cartilage-hair ...